Dermatophytosis (ringworm) is a superficial fungal infection in cats and dogs caused primarily by Microsporum canis, Microsporum gypseum, and Trichophyton mentagrophytes. In cats, more than 90% of cases are caused by M. canis. Dermatophytosis is an important zoonotic disease in veterinary dermatology and can spread to people, especially children and immunocompromised individuals. Cats may act as asymptomatic carriers and contaminate the environment without obvious lesions. This article reviews diagnostic methods, treatment protocols, environmental decontamination, and strategies for nutritional immune support.
Zoonotic Warning: It Spreads to Humans
- Dermatophytosis is transmissible to people, especially children, older adults, and immunocompromised individuals
- In humans it commonly causes ringworm, a circular, erythematous, pruritic skin lesion
- Both the infected animal and the contaminated environment serve as sources of infection
- If people in the household develop skin lesions at the same time, dermatology consultation is advisable
- Strict hygiene adherence is essential throughout treatment
1. Etiology: Major Dermatophyte Species
| Dermatophyte Species | Natural Host | Frequency | Key Features |
|---|---|---|---|
| Microsporum canis | Cat (primary host) | Cats: >90%; Dogs: ~70% | Most common species; asymptomatic carriage is common in cats; Wood lamp positive in about 50% of strains |
| Microsporum gypseum | Soil (geophilic) | 5-10% | Associated with soil exposure; digging or outdoor animals; often self-limiting |
| Trichophyton mentagrophytes | Rodents | 5-10% | Often associated with rodent exposure; may cause deep inflammatory lesions such as kerion |
2. Transmission and Risk Factors
- Direct contact: infected animal to healthy animal or human
- Fomites: combs, brushes, bedding, carriers, rugs, and furniture
- Environmental contamination: arthrospores can remain viable in the environment for 18-24 months
- Asymptomatic carriers: cats shedding spores despite having no obvious lesions
- Soil exposure: especially relevant for M. gypseum
- Juvenile animals: the immune system is still immature
- Long-haired cats: Persian and Himalayan cats have high carriage rates
- Shelters or multi-animal homes: dense populations favor spread
- FIV/FeLV-positive cats: immunosuppression increases susceptibility
- Stress and malnutrition: weaken immune defense
- Warm, humid environments: support fungal persistence
- Compromised skin barrier: wounds, eczema, and inflamed skin facilitate infection
Asymptomatic Carriage in Cats
Some cats, especially long-haired breeds, can carry M. canis spores without showing any clinical lesions and still contaminate the environment. This is one of the main reasons dermatophytosis spreads in shelters and multi-cat households. Asymptomatic carriers are typically identified by fungal culture and still require treatment (Moriello et al., 2017).
3. Clinical Signs
3.1 Clinical Presentation in Cats
- Well-circumscribed round alopecia: hairless areas with gray-white crusting
- Distribution: face, ears, nose, and distal limbs are common starting points
- Scaling and crusting: dandruff-like debris is common
- Pruritus: usually mild unless secondary bacterial infection is present
- Nail involvement: onychomycosis with brittle or deformed nails
- Miliary dermatitis: diffuse small crusts that can resemble allergic skin disease
- Asymptomatic carriage: no lesions despite positive culture
- Pseudomycetoma: a rare dermatophytic granuloma, especially in Persian cats
- Generalized disease: more likely in FIV/FeLV-positive cats
3.2 Clinical Presentation in Dogs
- Focal alopecia: round, crusted hairless lesions
- Kerion: inflammatory, swollen, painful lesions, especially with T. mentagrophytes
- Folliculitis: infection centered on the hair follicle
- Onychomycosis: fungal nail infection
- Yorkshire Terriers: recognized as a predisposed breed with potentially more severe disease
4. Diagnostic Methods
| Method | Description | Reliability | Clinical Note |
|---|---|---|---|
| Wood lamp examination | Ultraviolet light used to detect apple-green fluorescence of some M. canis infections | Low to moderate | Only about 50% of M. canis strains fluoresce; false negatives are common, and scale or topical products can cause false positives |
| Fungal culture (DTM) | Growth on Dermatophyte Test Medium | Gold standard | Results take 7-21 days; permits species identification and detection of asymptomatic carriers |
| PCR | Detection of dermatophyte DNA | High | Rapid turnaround, but cannot distinguish live from dead organisms; limited value for treatment monitoring |
| Direct microscopy (KOH) | Evaluation for arthrospores on hair and scale | Moderate | Fast but operator-dependent; a negative result does not rule out infection |
| Trichogram | Microscopic examination of plucked hairs | Moderate | Ectothrix arthrospores may be seen, but experience is required |
| McKenzie brush technique | Hair collection with a sterile toothbrush followed by culture | High | Especially valuable for screening asymptomatic carriage, particularly in cats |
The Wood Lamp Pitfall
Wood lamp screening is used frequently, but its reliability is limited. Only about half of M. canis strains fluoresce, and other dermatophyte species usually do not fluoresce at all. Scale, topical medications, and textile fibers can all create false-positive results. A negative Wood lamp examination therefore does not exclude dermatophytosis; diagnosis should ultimately be confirmed by fungal culture.
5. Treatment Protocol
The Three-Part Treatment Strategy
Effective dermatophytosis treatment has three pillars, and all three should be implemented together.
1. Systemic Antifungal Therapy
Oral itraconazole or terbinafine for at least 6-8 weeks, or until culture conversion
2. Topical Therapy
Antifungal shampoos such as 2% miconazole + 2% chlorhexidine, or lime sulfur dips, usually twice weekly
3. Environmental Decontamination
Removal of infective spores from the environment is essential for treatment success
5.1 Systemic Antifungal Drugs
| Drug | Dose | Duration | Clinical Note |
|---|---|---|---|
| Itraconazole | 5 mg/kg/day in cats and dogs | Minimum 6-8 weeks; pulse therapy may be used (1 week on, 1 week off) | First-line option; liver enzyme monitoring is advisable; administer with food |
| Terbinafine | 30-40 mg/kg/day in cats; 20-30 mg/kg in dogs | Minimum 6-8 weeks | An alternative to itraconazole; often well tolerated in cats and associated with fewer drug interactions |
| Griseofulvin | 25-50 mg/kg/day | Long-term use required | Older drug with more adverse effects, including bone marrow suppression; contraindicated in FIV-positive cats and teratogenic in pregnancy |
5.2 Criteria for Stopping Treatment
When Is Treatment Finished?
Treatment is stopped not when the skin looks better, but when fungal culture becomes negative. At least two consecutive negative cultures, collected two weeks apart, should be obtained. Premature discontinuation is a common cause of relapse. Average treatment duration is 6-12 weeks, but some cases require longer.
6. Environmental Decontamination
Dermatophyte arthrospores can remain viable in the environment for 18-24 months. Without environmental decontamination, treatment commonly fails.
- Daily vacuuming: remove hair and spores; dispose of vacuum contents immediately
- Surface disinfection: 1:10 bleach solution or enilconazole where appropriate
- Textile washing: bedding, blankets, and covers should be washed at 60°C
- Discarding heavily contaminated items: rugs, pillows, and grooming tools may need replacement
- Ventilation: warm, humid, poorly ventilated spaces favor fungal persistence
- Isolation: the infected animal should be confined to an area that is easy to clean
- Hand hygiene after contact: essential for all caregivers
- Hair clipping: whole-body clipping is no longer routinely advised, but targeted trimming around lesions may help in long-haired cats
- Other animals in the home: should be screened for carriage by culture
7. Nutritional Immune Support: The VetKriter Approach
VetKriter Nutrition Principle
Nutrition is not the primary treatment for dermatophytosis; antifungal therapy is essential. However, improving immune resilience can shorten the time required to control infection and may reduce recurrence. Shelter cats, young animals, and immunocompromised patients are the groups most likely to benefit from nutritional support.
| Nutritional Component | Immune / Skin Function | Typical Source |
|---|---|---|
| High-quality protein | Supports immunoglobulin synthesis, keratin production, and tissue repair | Animal-derived protein sources such as chicken, fish, and lamb |
| Zinc | T-cell function, keratinocyte proliferation, and antifungal defense | Zinc methionine or zinc proteinate in chelated form |
| Vitamin A | Supports epithelial barrier integrity and mucosal defense | Liver, fish oils, or fortified complete diets |
| Vitamin E + Selenium | Antioxidant protection and T-cell activation | Mixed tocopherols and selected plant oils |
| Omega-3 (EPA/DHA) | Anti-inflammatory effects and support for skin barrier recovery | Fish oil and salmon oil |
| Beta-glucan | Immunomodulation and macrophage activation relevant to antifungal defense | Yeast cell wall from Saccharomyces cerevisiae |
| Biotin (Vitamin B7) | Supports keratin synthesis and hair regrowth | Liver, eggs, and complete-diet fortification |
| Prebiotics (FOS/MOS) | Gut microbiome support with downstream systemic immune effects | Chicory root and mannan-oligosaccharides |
8. Management of Dermatophytosis in Shelters
Shelter Protocol
Admission and Screening:
- New admissions should be quarantined and screened with Wood lamp and fungal culture
- Long-haired cats should undergo McKenzie brush culture
- Positive animals should be treated in a dedicated isolation unit
- Asymptomatic carriers should also be treated
Treatment and Follow-up:
- Combined systemic and topical treatment is preferred
- Fungal culture follow-up should be repeated every two weeks
- Treatment is stopped only after two consecutive negative cultures
- Environmental decontamination must be performed daily
- Caregivers should use separate clothing for isolation and routine units
9. Prognosis and Relapse Prevention
- Immunocompetent adults: Prognosis is good; most recover completely with treatment, and some cases may be self-limiting over 3-5 months, although treatment prevents spread
- Young animals: Usually respond well, but risk of shelter-wide spread is high
- Immunosuppressed animals (FIV/FeLV): More difficult to treat, prone to relapse, and may require prolonged antifungal therapy
- Relapse prevention: environmental decontamination, stress reduction, high-quality nutrition, and immune support remain central
10. References
- Moriello KA, et al. Diagnosis and treatment of dermatophytosis in dogs and cats — Clinical Consensus Guidelines of the WAAVD. Vet Dermatol. 2017;28(3):266-e68.
- Moriello KA. Feline Dermatophytosis: Aspects Pertinent to Disease Management in Single and Multiple Cat Situations. JFMS. 2014;16(5):419-431.
- DeBoer DJ, Moriello KA. Development of an experimental model of Microsporum canis infection in cats. Vet Microbiol. 1994;42(2-3):289-295.
- Newbury S, et al. Use of itraconazole and either lime sulphur or Malaseb Concentrate Rinse to treat shelter cats naturally infected with Microsporum canis. JFMS. 2011;13(10):701-707.
- Bond R. Superficial veterinary mycoses. Clin Dermatol. 2010;28(2):226-236.
- ABCD (European Advisory Board on Cat Diseases). Dermatophytosis in Cats Guidelines. 2023.
- WSAVA Global Nutrition Committee. Nutritional Assessment Guidelines. 2024.